Recombinant Mouse Junctional adhesion molecule A (F11r)

What are the structural domains of mouse F11r/JAM-A and their functional significance?

Mouse F11r/JAM-A contains several critical structural domains:

• Extracellular region with two immunoglobulin-like domains (amino acids 1-238) involved in homophilic and heterophilic interactions

• Single transmembrane domain

• Cytoplasmic region containing phosphorylation sites and a PDZ-binding motif

The extracellular domain appears early in primordial forms of cell junctions and recruits PARD3 . The cytoplasmic region participates in tight junction assembly, intracellular signaling pathways, and cell polarity regulation . Of particular importance, the PDZ-binding motif allows F11r/JAM-A to directly interact with at least nine different PDZ domain-containing proteins , explaining its diverse biological activities despite lacking intrinsic catalytic activity.

Which expression systems provide optimal yield and proper folding for recombinant mouse F11r/JAM-A?

For production of functional recombinant mouse F11r/JAM-A, mammalian expression systems are strongly preferred over bacterial systems because:

• HEK293 cells: Most commonly used for proper folding and post-translational modifications, especially glycosylation

• Human cells: Effective for producing Fc-tagged fusion proteins with >94% purity

Methodology for optimal expression:

• Clone mouse F11r (NP_766235.1) extracellular domain (Met 1-Ala 242) with appropriate tag

• Transfect expression vector into HEK293 cells using calcium phosphate or lipid-based transfection

• Harvest supernatant after 48-72 hours

• Confirm expression in cell lysates by western blot

The choice of expression system significantly impacts protein functionality, particularly for studies examining protein-protein interactions or structural analyses.

What purification strategy yields highest purity and maintains functional integrity of recombinant mouse F11r/JAM-A?

A multi-step purification protocol is recommended:

• Initial capture: Anti-tag affinity chromatography

  • For His-tagged proteins: Immobilized metal affinity chromatography

  • For Fc-tagged proteins: Protein A/G affinity columns

• Secondary purification:

  • Size exclusion chromatography to remove aggregates

  • Ion exchange chromatography for final polishing

• Quality control:

  • SDS-PAGE with Coomassie staining (target >94% purity)

  • Endotoxin testing (<1 EU/μg)

  • Functional verification (binding assays)

Critical considerations include buffer composition (typically 25 mM Tris-HCl, 100 mM glycine, pH 7.3, with 10% glycerol) and storage conditions (store at -80°C and avoid repeated freeze-thaw cycles).

How can researchers accurately assess homophilic and heterophilic interactions of mouse F11r/JAM-A?

Several methodological approaches can be employed:

• Local fluorescent signal correlation analysis:

  • Create a sliding window method to measure local signal correlation

  • Use 9×9 pixel window (1.85×1.85μm) for optimal balance between minimizing noise and maintaining sensitivity

  • Generate correlation maps to analyze recruitment dynamics at adhesion sites

• Surface Plasmon Resonance (SPR):

  • Immobilize recombinant JAM-A on a sensor chip

  • Flow potential binding partners at various concentrations

  • Analyze association/dissociation rates to determine binding constants

  • Include cation effects (Ca²⁺, Mg²⁺, etc.) in binding buffer to assess their role as molecular switches

• Co-immunoprecipitation assays:

  • Examine JAM-A dimerization status following activation

  • Investigate association with binding partners like integrin GPIIIa and CD9

These approaches provide complementary information about JAM-A's diverse molecular interactions and should be combined for comprehensive characterization.

What methodologies are most effective for studying F11r/JAM-A's role in tight junction formation?

To study F11r/JAM-A's role in tight junction assembly:

• Loss-of-function approaches:

  • Use shRNA to deplete JAM-A in primary epithelial cells

  • Quantify effects on transepithelial resistance (typically 30% decrease in JAM-A-depleted cells)

  • Monitor expression/localization of tight junction scaffold proteins (ZO-1) and structural transmembrane proteins (claudin-18)

• Rescue experiments:

  • Re-express wild-type or mutant JAM-A in knockdown cells

  • Focus on key domains: PDZ-binding motif, dimerization interface, phosphorylation sites

• Molecular interaction studies:

  • Investigate JAM-A's recruitment of PARD3 using fluorescence microscopy

  • Examine how PARD6-PARD3 complex affects JAM-A-PARD3 interactions

  • Study JAM-A's direct interaction with ZO-2 and subsequent recruitment of other scaffold proteins (ZO-1, afadin, PDZ-GEF1, Rap2c)

These approaches should be conducted in relevant cell types (epithelial or endothelial) to maintain physiological relevance.

How do cis and trans interactions of mouse F11r/JAM-A differentially regulate downstream signaling pathways?

Distinguishing between cis (same cell) and trans (adjacent cell) interactions requires sophisticated experimental approaches:

• Mutational analysis:

  • Generate dimerization-deficient mutants that specifically disrupt cis or trans interactions

  • Assess effects on JAM-C replacement by electroporating cDNA with specific mutations

  • Analyze downstream signaling through small GTPases (Rap2c and RhoA)

• Spatial organization analysis:

  • Calculate spatial distribution of correlation at adhesion periphery

  • Analyze the 0.5 μm edge around JAM adhesions

  • Plot ratio of peripheral to whole adhesion values of correlation and area

  • Higher proportion of positive JAM:drebrin correlation at adhesion periphery indicates peripheral distribution during adhesion formation

• Biochemical discrimination:

  • Use cross-linking reagents with different spacer arm lengths to distinguish between cis and trans dimers

  • Employ proximity ligation assays to visualize specifically cis or trans interactions in situ

This methodology allows researchers to dissect the specific contributions of different interaction modes to JAM-A's diverse functions.

What experimental approaches can reveal the phosphorylation-dependent regulation of mouse F11r/JAM-A functions?

To investigate phosphorylation-dependent regulation:

• Site-specific phosphorylation analysis:

  • Focus on key sites in the cytoplasmic region, particularly Tyr280 and Ser284

  • Generate phosphomimetic (D/E substitution) and phosphodeficient (A substitution) mutants

  • Assess effects on:

    • Tight junction assembly

    • Intracellular signaling

    • Cell polarity regulation

• Kinase identification:

  • For platelet activation, investigate phosphoinositide-3 kinase activity using specific inhibitors like wortmannin

  • Examine F11R dimerization and association with integrin GPIIIa and CD9 following phosphorylation

• Molecular consequence analysis:

  • Determine how phosphorylation affects interaction with PDZ domain-containing proteins

  • Assess impact on subcellular localization and protein stability

  • Examine phosphorylation status during specific biological processes (e.g., tight junction disassembly during inflammation)

These approaches help elucidate how post-translational modifications regulate F11r/JAM-A's multifunctional capabilities.

What methodologies best evaluate mouse F11r/JAM-A's tissue-specific roles in cancer progression?

F11r/JAM-A shows complex, tissue-specific patterns in cancer as summarized in this data table:

To investigate these complexities, researchers should employ:

• Tissue-specific expression modulation:

  • Use inducible, tissue-specific knockout/knockdown models

  • Apply CRISPR/Cas9 to generate cell-type specific mutations

  • Compare effects across multiple cancer types

• Transendothelial migration (TEM) assays:

  • Utilize F11R/JAM-A antagonistic peptides (e.g., peptide 4D) to block function

  • Measure cancer cell adhesion to endothelium and transendothelial migration

  • Assess soluble F11R/JAM-A (sJAM-A) levels by ELISA as potential biomarkers

• Mechanistic pathway investigation:

  • Study EMT markers following JAM-A modulation

  • Characterize signaling pathway differences between cancer types

This methodological approach allows reconciliation of apparently contradictory findings across different cancer types.

How can researchers effectively design and evaluate F11r/JAM-A-derived peptides for potential therapeutic applications?

For developing F11r/JAM-A-based therapeutics:

• Rational peptide design:

  • Identify active site sequences in N-terminal and first Ig-loop regions that mediate homophilic interactions

  • Use in silico modeling of polypeptide chain complexes to predict inhibitory candidates

  • Incorporate D-amino acids (D-Arg, D-Lys) at strategic positions to enhance stability against proteolysis

  • Example: 2HN-(dK)-SVT-(dR)-EDTGTYTC-CONH2 shows promising activity

• Functional validation assays:

  • Test inhibition of antibody-induced platelet aggregation

  • Evaluate prevention of adhesion to cytokine-inflamed endothelial cells

  • Assess effects on transendothelial migration (TEM) of cancer cells

  • Measure endothelial permeability using fluorescent tracer assays

• Pharmacological characterization:

  • Determine peptide stability in biological fluids

  • Assess potential off-target effects on normal tight junction function

  • Compare effectiveness with established barrier-protective compounds (e.g., forskolin)

This systematic approach can help develop novel therapeutics targeting atherosclerosis, thrombosis, inflammatory conditions, and cancer metastasis.

What advanced techniques can assess F11r/JAM-A's role in endothelial barrier function during inflammation?

To investigate F11r/JAM-A's role in endothelial barrier function:

• Real-Time Cell Analysis (RTCA):

  • Monitor endothelial barrier integrity in real-time

  • Assess effects of inflammatory cytokines on barrier function

  • Evaluate the protective effect of F11R/JAM-A-derived peptides

  • Compare effectiveness of peptide 4D (P4D) with established compounds like forskolin

• Mechanistic dissection:

  • Examine JAM-A's association with PAR-3 and ZO-1 during inflammation

  • Investigate how these interactions affect the cortical actin cytoskeleton

  • Study actomyosin-dependent tension on adherens junctions

  • Monitor junctional localization of JAM-A and tight junction proteins like claudin-5

• In vivo inflammation models:

  • Use models of mild systemic endotoxemia (LPS injection)

  • Evaluate JAM-A expression and localization during inflammatory response

  • Assess barrier protection by JAM-A-derived peptides

  • Study JAM-A's role in regulating monocyte transmigration and epithelial barrier integrity

These methodologies provide a comprehensive understanding of how F11r/JAM-A regulates endothelial barrier function under inflammatory conditions, offering insights for therapeutic development.

How can researchers accurately characterize the PDZ domain interactions of mouse F11r/JAM-A?

F11r/JAM-A's diverse functions largely depend on interactions with PDZ domain-containing proteins. To study these interactions:

• Systematic interaction mapping:

  • Use yeast two-hybrid screening with JAM-A's cytoplasmic domain as bait

  • Perform pull-down assays with recombinant PDZ domains

  • Identify which of the nine known PDZ domain interactions are most critical for specific functions

• Structural biology approaches:

  • Obtain co-crystal structures of JAM-A cytoplasmic domain with PDZ domains

  • Use NMR to characterize dynamic aspects of these interactions

  • Apply hydrogen-deuterium exchange mass spectrometry to map interaction surfaces

• Functional consequence analysis:

  • Generate specific mutations in the PDZ-binding motif that disrupt interactions with particular PDZ proteins

  • Create chimeric proteins where JAM-A's PDZ-binding motif is replaced with motifs having different specificities

  • Examine effects on tight junction assembly, barrier function, and signaling complex formation

This methodological approach allows precise dissection of how specific PDZ interactions contribute to JAM-A's multiple biological functions.

What experimental strategies can reveal the dynamic assembly of F11r/JAM-A-containing protein complexes during junction formation?

To investigate the temporal dynamics of JAM-A complex assembly:

• Live-cell imaging approaches:

  • Express fluorescently-tagged JAM-A and partner proteins

  • Use FRAP (Fluorescence Recovery After Photobleaching) to assess protein dynamics

  • Apply FRET-based sensors to monitor protein-protein interactions in real-time

  • Implement the local correlation analysis within sliding windows as described in the search results

• Sequential recruitment analysis:

  • Use synchronized junction formation models (calcium switch assays)

  • Collect samples at defined time points for biochemical and microscopic analysis

  • Determine the order of protein recruitment (JAM-A → PARD3 → tight junction proteins)

  • Examine how PARD6-PARD3 complex may prevent PARD3-JAM1 interaction

• Super-resolution microscopy:

  • Apply techniques like STORM, PALM, or cryo-CLEM to visualize spatial organization at nanoscale resolution

  • Analyze adhesion edge morphology, where JAM-to-drebrin correlation appears highest

  • Study drebrin peripheral distribution during adhesion formation